Federal Register / Vol. 62, No. 5 / Wednesday, January 8, 1997 / Notices 1127

Time of Meeting: 8:00 a.m.

Place of Meeting: Holiday Inn Georgetown,

2101 Wisconsin Avenue, Washington, D.C.

20007.

Agenda: Discussion of Future Initiatives

with Emphasis on Stored Samples for

Genetic Research.

Contact Person: Susan E. Old, Ph.D.,

NHLBI/DHVD, Two Rockledge Center, 6701

Rockledge Drive, Rm. 9150, MSC 7940,

Bethesda, Maryland 20892, (301) 435–0560.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health)

Dated: December 30, 1996.

Paula N. Hayes,

Acting Committee Management Officer, NIH.

[FR Doc. 97–326 Filed 1–7–97; 8:45 am]

BILLING CODE 4140–01–M

National Heart, Lung, and Blood

Institute; Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Heart,

Lung, and Blood Special Emphasis

Panel (SEP) meeting:

Name of SEP: Tuberculosis Academic

Award Review.

Date: January 28, 1997.

Time: 9:00 a.m.

Place: Chevy Chase Holiday Inn, 5520

Wisconsin Avenue, Chevy Chase, Maryland

20815.

Contact Person: Louise P. Corman, Ph.D.,

Two Rockledge Center, Room 7180, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0270.

Purpose/Agenda: To review and evaluate

grant applications.

Name of SEP: Reference Laboratory to

Evaluate Therapies for Sickle Cell Disease

(Telephone Conference Call).

Date: February 26, 1997.

Time: 1:30 p.m.

Place: Rockledge Building II, Room 7214,

6701 Rockledge Drive, Bethesda, Maryland

20892.

Contact Person: Diane M. Reid, M.D., Two

Rockledge Center, Room 7182, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0277.

Purpose/Agenda: To review and evaluate

grant applications.

Name of SEP: Molecular Genetics of

Coagulation Disorders.

Date: February 26–27, 1997.

Time: 7:30 p.m.

Place: Holiday Inn Bethesda, 8120

Wisconsin Avenue, Bethesda, Maryland

20814.

Contact Person: Louis M. Ouellette, Ph. D.,

Two Rockledge Center, Room 7216, 6701

Rockledge Driver, Bethesda, MD 20892–7924,

(301) 435–0310.

Purpose/Agenda: To review and evaluate

grant applications.

Name of SEP: Hepatic Gene Therapy for

Hemophilia B.

Date: February 27–28, 1997.

Time: 7:30 p.m.

Place: Holiday Inn Bethesda, 8120

Wisconsin Avenue, Bethesda, Maryland

20814.

Contact Person: Louis M. Ouellette, Ph.D.,

Two Rockledge Center, Room 7216, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0310.

Purpose/Agenda: To review and evaluate

grant applications.

These meetings will be closed in

accordance with the provisions set forth

in sections 552b(c)(4) and 552b(c)(6),

Title 5 U.S.C. Applications and/or

proposals and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with

the applications and/or proposals, the

disclosure of which would constitute a

clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health)

Dated: December 30, 1996.

Paula N. Hayes,

Acting Committee Management Officer, NIH.

[FR Doc. 97–328 Filed 1–7–97; 8:45 am]

BILLING CODE 4140–01–M

National Heart, Lung, and Blood

Institute; Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Heart,

Lung, and Blood Special Emphasis

Panel (SEP) meetings:

Name of SEP: Radio Frequency Coils for

High Field MRI (Telephone Conference Call).

Date: January 22, 1997.

Time: 2:00 p.m.

Place: Rockledge Building Two, Room

7214, 6701 Rockledge Drive, Bethesda,

Maryland.

Contact Person: Ivan Baines, Ph.D., Two

Rockledge Center, Room 7184, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0277.

Purpose/Agenda: To review and evaluate

contract proposals.

Name of SEP: ECG Monitoring in MRI to

Detect Cardiac Ischemia (Telephone

Conference Call).

Date: January 22, 1997.

Time: 2:45 p.m.

Place: Rockledge Building Two, Room

7214, 6701 Rockledge Drive, Bethesda,

Maryland.

Contact Person: Ivan Baines, Ph.D., Two

Rockledge Center, Room 7184, 6701

Rockledge Drive, Bethesda, MD 20892–7924,

(301) 435–0277.

Purpose/Agenda: To review and evaluate

contract proposals.

These meetings will be closed in

accordance with the provisions set forth

in sections 552b(c) (4) and 552b(c) (6),

Title 5, U.S.C. Applications and/or

proposals and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with

the applications and/or proposals, the

disclosure of which would constitute a

clearly unwarranted invasion of

personal privacy.

This notice is being published less

than fifteen days prior to these meetings

due to the urgent need to meet timing

limitations imposed by the contract

review and funding cycle.

(Catalog of Federal Domestic Assistance

Programs Nos. 93.837, Heart and Vascular

Diseases Research; 93.838, Lung Diseases

Research; and 93.839, Blood Diseases and

Resources Research, National Institutes of

Health)

Dated: December 30, 1996.

Paula N. Hayes,

Acting Committee Management Officer, NIH.

[FR Doc. 97–329 Filed 1–7–97; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Neurological

Disorders and Stroke; Notice of

Meetings

Pursuant to Public Law 92–463,

notice is hereby given of meetings of the

National Institute of Neurological

Disorders and Stroke (NINDS).

The National Advisory Neurological

Disorders and Stroke Council and its

subcommittee meetings will be open to

the public as indicated below.

Attendance by the public will be limited

to space available.

The meetings will be closed to the

public as indicated below in accordance

with the provisions set forth in sections

552(c)(4) and 552b(c)(6), Title 5, U.S.C.

and section 10(d) of Public Law 92–463,

for the review, discussion and

evaluation of individual grant

applications. These applications and

discussions could reveal confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Summaries of meetings, rosters of

committee members, and other

information pertaining to the meetings

can be obtained from the Executive